Core histone mRNA levels are exquisitely regulated within cells 1,2 . Histone transcription is initiated at the G1/S phase and is actively downregulated during the late S and G2 phases to avoid overproduc tion soon after the completion of DNA synthesis in the S phase [3] [4] [5] [6] [7] [8] . Eukaryotic cells have evolved multiple mechanisms to maintain appropriate histone abundance during the cell cycle. One of the most extensively studied mechanisms that operates in all higher eukaryotes is the increased turnover of histone mRNAs 9 . Recently, another mechanism was reported in Schizosaccharomyces pombe in which the activator for histone transcription is actively degraded, resulting in histone transcriptional downregulation 10 . It is prob able that in higher eukaryotes, histone transcript turnover may not be sufficient to accomplish a rapid decrease in histone transcript abundance. Cells would also need to shut off histone transcription at the end of DNA synthesis to avoid burdening the histone turn over machinery to downregulate histone abundance. The impor tance of histone transcriptional shutdown was noted as early as the late 1980s 11 ; however, little progress has since been made in terms of how this crucial process is precisely regulated in a cell cycledependent manner.
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Tyrosine kinases regulate key cellular processes, including cell growth, proliferation and differentiation. Although the cytosolic effec tors of most tyrosine kinases have been well studied, direct epigenetic modulation by tyrosine phosphorylation is a relatively new subject of study 12, 13 . Multiple wellconserved tyrosine residues are present in histones. However, the phosphorylation status and physiological functions of the majority of these tyrosine residues are unknown. We therefore sought to address this relatively understudied epige netic modification. Using a mass spectrometry-based approach, we discovered that in mammalian cells, histone H2B is phosphorylated at Tyr37 during the late S phase upstream of the Hist1 cluster, where about 80% of the histone genes are located. In higher eukaryotic cells, histone transcription is regulated at the transcriptional and post transcriptional levels 3, 9 . For example, in synchronized HeLa cells, the rate of histone mRNA synthesis increases approximately threefold during the initial 2.5 h after release from the thymidine and aphidicolin block at the G/S boundary 2 . The abundance of nuclear histone mRNA reaches its maximum by the second hour after entry into S phase and remains at that level until the end of the S phase; mRNA levels then drop steeply at the end of the S phase 2 . Soon after transcription, histone mRNAs are subjected to posttranscriptional processing and increase in stability 9 . A cumulative effect of these two processes is an increase of approximately 15 to 20fold in steadystate histone mRNA levels in the S phase. At the end of the S phase, cells switch off histone transcrip tion. How cells terminate histone transcription is unknown. Here we report that phosphorylation of H2B at Tyr37 by WEE1 leads to coordinated transcriptional suppression of replicationdependent core histone genes in the late S/G2 phase.
Wee1, discovered for its small size as a cdc (cell division cycle) mutant in the fission yeast S. pombe, is evolutionarily conserved. WEE1 is a nuclear tyrosine kinase that negatively regulates the activ ity of the cyclindependent kinase Cdc2 by tyrosine phosphorylation to prevent mitotic entry before the completion of DNA synthesis [14] [15] [16] . The expression of WEE1 protein is tightly regulated in cells. Its expression peaks during the S phase and is quickly degraded in the G2 phase. We show here for the first time that WEE1 kinase, previ ously established as a cellcycle regulator, is a new epigenetic modifier of histone H2B.

RESULTS
Identification of Tyr37-phosphorylated H2B in late S phase
To delineate the functional consequences of histone tyrosine phospho rylation, we subjected purified histones to mass spectrometry-based identification of posttranslational modifications. Using this method, we identified a previously unreported phosphorylation at Tyr37 in histone H2B (Supplementary Fig. 1 ). As the functional role of Tyr37 phosphorylated H2B (pTyr37 H2B) is unknown, we raised phospho specific antibodies to pTyr37 H2B, which we extensively validated (Supplementary Figs. 2-4) . We compared the recognition of differ ent H2B peptides by the antibodies to pTyr37 H2B and found that these antibodies recognized only the H2B phosphopeptide that was phosphorylated at Tyr37, but not the nonphosphorylated H2B peptide or the H2B peptide harboring a Y37F substitution ( Supplementary  Fig. 2a) . Further, competition of pTyr37 H2B antibodies with phos phopeptide resulted in almost complete loss of recognition of Tyr37 H2B phosphopeptide (Supplementary Fig. 2b,c) . We also screened the pTyr37 H2B antibodies for crossreactivity with 59 distinct acetylation, methylation, phosphorylation and citrullination modi fications on core histones using histone peptide arrays. The pTyr37 H2B antibody did not crossreact with any of these posttranslational modifications; however, when we hybridized the same blots with his tone H3 trimethyl Lys9 (H3K9me3) antibodies, the expected pattern of hybridization was produced (Supplementary Fig. 2d ). In addition, immunoblotting with wholecell extracts revealed a band of ~15 kDa (Supplementary Fig. 2e ). Collectively, these data indicate that the antibodies are selective for Tyr37phosphorylated H2B.
A mass spectrometry-based analysis revealed that in asynchro nously growing cultures, the amount of pTyr37 H2B is 0.21% that of the total H2B protein (Supplementary Table 1) , which suggested that H2B could be tyrosine phosphorylated transiently during the cell cycle and then rapidly dephosphorylated. To assess the cell cycle-specific expression of pTyr37 H2B, we synchronized mouse embryo fibroblasts (MEFs) by double thymidine block, which arrests cells at the G1/S boundary, released them into fresh medium and collected the aliquots after various time intervals. We confirmed the synchronization of the cells by immunoblotting with cyclin A2, cyclin E and pTyr15 Cdc2 antibodies, as well as by flow cytometry (Supplementary Fig. 3a-c) . These experiments collectively indicate that the majority of the cells were arrested at the G1/S boundary by the thymidine block; the cells progressed into the cell cycle synchronously to reach mid S phase by about 4 h, late S phase by 6.5-7 h and the G2/M phase by about 8-9 h after thymidine release into fresh medium.
We detected pTyr37 H2B at 6.25-6.75 h after thymidine release, and the amount of pTyr37 H2B peaked at 6.5 h after release (Fig. 1a and  Supplementary Fig. 3a) . Synchronized H1975, a human lung cancer cell line, also contained pTyr37 H2B at 6.5 h after thymidine release (data not shown). An 5ethynyl2deoxyuridine (EdU) incorporation assay of MEFs at 6.5 h after thymidine release revealed that a substan tial proportion were in the late S phase (Supplementary Fig. 3c and Supplementary Note).
WEE1 kinase phosphorylates H2B at Tyr37
To identify a kinase that can target H2B for Tyr37 phosphorylation, we assessed multiple kinases, including receptor tyrosine kinases such as EGFR, HER2, PDGFR, FGFR and IR. We also assessed non receptor tyrosine kinases, including Src, Abl and Ack1 (also known as TNK2), for their ability to phosphorylate H2B. However, none of these kinases could phosphorylate H2B in vivo (data not shown). During the S phase, temporal regulation of the expression of WEE1 kinase and the tyrosine phosphorylation of its substrate, Cdc2, is well estab lished 14, 16, 17 . To examine whether H2B is a WEE1 kinase substrate, we treated H1975 cells with increasing concentrations of a WEE1 inhibitor, MK1775 (ref. 18) . Even treatment with a 0.3 µM concentra tion of this WEE1 inhibitor resulted in the complete loss of the H2B Tyr37 phosphorylation mark (H2BpY37) (Fig. 1b) . Similarly, trans fection of the cells with WEE1 short interfering RNA (siRNA) also resulted in the complete loss of H2BpY37 (Fig. 1c) . To test whether WEE1 directly phosphorylates H2B, we performed an in vitro kinase assay 19 . When we incubated purified WEE1 and H2B together, H2B was phosphorylated at Tyr37, and this phosphorylation was abro gated by treatment with the WEE1 inhibitor (Fig. 1d) (Supplementary Fig. 4a ). Moreover, WEE1 specifi cally phosphorylated H2B but not three other core histones, H2A, H3 and H4 in vitro (Fig. 1e) . To determine the direct binding of WEE1 to H2B in vivo, we coimmunoprecipitated WEE1 and H2B, which revealed formation of endogenous WEE1-pTyr37 H2B complexes (Fig. 1f) . We also confirmed the binding of WEE1 to endogenous H2B as well as the phosphorylation of H2B by transfecting Myctagged WEE1 (Supplementary Fig. 4b) .
To further validate H2B as a substrate for WEE1 kinase in vivo, we generated Flagtagged constructs expressing either wildtype or Y37F mutant H2B. Coexpression of the two forms of H2B with wildtype (WT) WEE1 or kinasedead WEE1 revealed that WT WEE1 specifi cally phosphorylated H2B but did not phosphorylate the Y37F H2B mutant (Fig. 1g) . To determine whether WEE1 kinase can phospho rylate other core histones in vivo, we transfected cells with the WEE1 kinase and immunoprecipitated the core histones. Immunoblotting with antibodies to pTyr37 H2B revealed that the WEE1 kinase phos phorylated H2B but not other core histones under these conditions (Supplementary Fig. 4c ). Collectively, these data indicate that WEE1 kinase specifically phosphorylates H2B at Tyr37.
H2BY37 phosphorylation occurs upstream of Hist1
To identify regions in chromatin where H2B Tyr37 phosphoryla tion occurs, we performed a native chromatin immunoprecipitation (ChIP)coupled DNA microarray analysis (ChIPonchip) 20 and native ChIP sequencing (Supplementary Note). We immunoprecipitated the sheared chromatin from synchronized MEFs (0 h and 6.5 h after thymidine release) using the pTyr37 H2B antibody or IgG and then sequenced the resulting DNA. This led to the identification of 3,524 potential sites and regions where pTyr37 H2B is present in the mouse genome; l,240 of these sites were within genes, whereas 351 sites were located upstream and 326 sites were located downstream of genes ( Supplementary Tables 2 and 3) . The MEME motif search tool found 20 unique motifs in our ChIP data (Supplementary Table 4 ). An analysis of these 20 motifs using FIMO is shown in Supplementary Table 5 . Based on the GCrich content and highest E value, we used the motif termed 'motif 3' to search all the ChIP data using the MAST program.
This screen revealed 511 genes that could potentially be regulated by H2B Tyr37 phosphorylation (Supplementary Table 6 ). In addition, using MetaCore, we ran several enrichment analyses to cluster genes adjacent to the ChIP sequencing peaks. The gene clusters are shown in Supplementary Figure 5b based on their functional role.
A native ChIPonchip analysis revealed two sites containing pTyr37 H2B, named here site 1 and 2, upstream of histoneencoding genes of Hist1 (Supplementary Table 3 ). Notably, motif 3 was also present in both site 1 and site 2 ( Supplementary Fig. 5a ). Collectively, these data opened the possibility that histone expression is regulated by a modified histone. We chose to investigate this finding further because of the novelty of the observation. The genes for the five his tones H1, H2A, H2B, H3 and H4 are clustered together in the genomes of all metazoans. There are 10-20 functional copies of these genes for each of the histone proteins, and each individual gene encodes a fraction of the total histone protein. In mammals, the genes for the core histones are clustered together in two loci, Hist1 and Hist2. The largest cluster, HIST1, is located on chromosome 6 in humans and chromosome 13 in mice [21] [22] [23] . The mouse and human histone gene clusters have strikingly similar gene numbers and organizations. The mouse Hist1 cluster contains the majority of the histonecoding genes: 45 core histone genes and 6 histone H1 genes 1, 23 . The histone genes in the Hist1 cluster are arranged in three subclusters. About a third of the histone genes located in subcluster 1 are closest to sites 1 and 2 (Fig. 2a) ; we analyzed some of these genes in this study.
To validate the presence of pTyr37 H2B upstream of the Hist1 cluster, we immunoprecipitated sheared chromatin from synchronized MEFs (0 h and 6.5 h after thymidine release) using the pTyr37 H2B antibody, followed by quantitative PCR (ChIPqPCR) 24, 25 . The primers used for ChIP DNA amplification are shown in Supplementary Table 7 . This method revealed that pTyr37 H2B is present at both site 1 and site 2; however, phosphorylation at these sites was significantly reduced by treatment with the WEE1 inhibitor (Fig. 2b,c) . As a control, we used primers corresponding to the 'gene desert' on chromosome 6 where we did not detect any pTyr37 H2B (control site, Fig. 2d ). To assess whether WEE1 regulates H2B Tyr37 phosphorylation upstream of the Hist1 cluster, we performed ChIPqPCR using WEE1 antibodies. The amount of WEE1 at site 2, but not at the control site, was significantly (Fig. 2e,f) . To fur ther validate the role of WEE1, we transfected cells with WEE1 or control siRNAs and performed ChIPqPCR using pTyr37 H2B anti bodies. There was a significant decrease in site 2-specific chromatin immunoprecipitated DNA in samples transfected with WEE1 siRNA compared to the sample transfected with control siRNA (Fig. 2g,h) , indicating a functional, WEE1kinase-dependent association of pTyr37 H2B with the Hist1 gene cluster.
H2BTyr37 phosphorylation regulates transcription of histones
Whereas the modification of core histones has been shown to regu late transcription [26] [27] [28] [29] , the transcription of the histones themselves is not known to be regulated by histone tyrosine phosphorylation. We assessed the expression of histone mRNA in synchronized MEFs and observed that core histone mRNA levels increased rapidly within 2 h after thymidine release, which is consistent with data from synchro nized HeLa cells 2 . However, at 6.5 h after thymidine release, when cells are in the late S phase and H2B is phosphorylated at Tyr37, we found a sharp decline in histone mRNA levels (Fig. 3a,b) . To investigate whether pTyr37 H2B has a direct role in regulating the transcription of histone genes, we treated synchronized MEFs with the WEE1specific inhibitor MK1775 (or left the MEFs untreated as a control group) and then performed qRTPCR for the individual histone genes. In untreated cells, we found a rapid decrease in the number of transcripts of multiple core histone genes after 6.5 h after thymidine release (Fig. 3c-k) . Notably, histone mRNA levels did not decrease in the cells treated with the WEE1 inhibitor ( Fig. 3c-g,j,k) . Indeed, for H2Ai and H2Ak, we found a significant increase in histone mRNA levels (Fig. 3h,i) . Histones H2Bk and H4h, which are located in the histone subclusters 2 and 3, respectively, also had significant increases in the number of transcripts after treatment with the WEE1 inhibitor (Fig. 3j,k) . The histone H1b had a modest increase in its transcript levels after treatment with the WEE1 inhibitor (Fig. 3l) . As a control, we assessed the transcript abundance of a variant histone, H2AX, whose transcription is regulated in a cell cycle-independent manner. Histone H2AX transcript levels did not change significantly as a result of treatment with the WEE1 inhibitor (Fig. 3m) . We also confirmed that Sphase progression was not overtly affected by WEE1 inhibition by performing a flow cytometric analysis of these cells (Supplementary Fig. 3b) . To directly show a role of H2B Tyr37 phosphorylation in suppressing histone transcription, we performed a nuclear runon assay (Supplementary Note). We labeled the nascent transcripts with biotinUTP, followed by purification using strept avidin beads. qRTPCR revealed a significant increase in histone mRNA synthesis in cells treated with the WEE1 inhibitor (Fig. 3n) . Collectively, these data indicate that H2B Tyr37 phosphorylation may have a repressive effect on the transcription of the core histone genes located in the Hist1 cluster.
H2B Tyr40 phosphorylation in Saccharomyces cerevisiae
Because multiple functional genes are available for each of the core histones in higher eukaryotes, performing mutational studies is chal lenging. The budding yeast S. cerevisiae has been used extensively as a model organism to study the roles of a variety of posttranslational modifications in histones [30] [31] [32] and of histone transcriptional activa tion 3, [5] [6] [7] [8] 11 . In S. cerevisiae, histones are transcribed from four sets of gene pairs, HTA1HTB1 and HTA2HTB2 for H2A and H2B and HHF1HHT1 and HHT2HHF2 for H3 and H4 (refs. 3,5-7) . Similarly to what occurs in metazoans, transcription is activated at the G1/S transition and is repressed in the G1 and G2/M phases of the cell 
We observed that the Tyr37 site is evolutionarily con served, including in unicellular eukaryotes-for example, Tyr40 in S. cerevisiae (Supplementary Fig. 6a ). As Tyr37 is invariant from human to yeast and a point mutant of H2B lacking the Tyr40 site is available in S. cerevisiae 33 , we assessed histone transcription in yeast cells expressing the Y40A mutant of H2B. We synchronized WT and Y40A H2B mutant S. cerevisiae cells by adding αfactor, after which we resuspended them in fresh medium and harvested them at different time points. We found H2B Tyr40 phosphorylation at approximately 30 min after release from αfactor; in contrast, H2B Tyr40 phosphor ylation was abrogated in the Y40A H2B mutant yeast ( Supplementary  Fig. 6b ). To examine histone transcription, we isolated mRNAs from WT and Y40A H2B mutant yeast and then performed qRTPCR. The WT cells had peak histone mRNA synthesis at 30 min after αfactor release, which was followed by a rapid decrease in mRNA synthesis ( Fig. 4a-d) . In contrast, H2B Y40A mutant yeast had significantly higher HTA1, HTB1, HHF1 and HHT1 mRNA levels than WT yeast at 30 min after αfactor release, which remained elevated until the end of cell cycle at ~50 min after αfactor release ( Fig. 4a-d) .
To determine whether H2B Tyr40 phosphorylation occurs in yeast histone promoters, we performed native ChIP followed by qPCR using primers corresponding to the promoter of the HTA1HTB1 loci (Supplementary Fig. 6c ). H2B Tyr40 phosphorylation was enriched in the promoter region containing the NEG site at 30 min after αfactor release in WT cells but not in the Y40A H2B mutant cells (Supplementary Fig. 6d) . Collectively, these data indicate that H2B Tyr40 phosphorylation is required for the suppression of yeast histone transcription. We found that WEE1 kinase regulates histone transcrip tional repression in mammalian cells. To assess whether yeast cells use a similar strategy, we used a yeast mutant lacking the homolog of WEE1 in S. cerevisiae, SWE1 (refs. 34, 35) . H2B was phosphorylated in the WT but not in the SWE1 mutant (swe1∆) yeast cells ( Supplementary  Fig. 6e ). To determine whether loss of SWE1, and thus loss of Tyr40 phosphorylation of H2B, would also lead to the loss of transcriptional suppression of yeast histones, we performed qRTPCR on RNA isolated from WT and swe1∆ mutant yeast. As seen in mammalian cells, loss of SWE1 in yeast resulted in a marked increase in HTA2, HTB2, HTA1, HHF1 and HTB1 mRNA levels ( Fig. 4e-i) . Taken together, these data indi cate that the WEE1 kinase, its substrate and the posttranslational modification are all conserved in yeast.
We performed a fluorescenceactivated cell sorting analysis to determine whether the increase in histone gene expression was the result of an altered cellcycle profile of the Y40A H2B mutant cells (Supplementary Note). We released synchronized WT and Y40A H2B mutant S. cerevisiae cells into yeast extract peptone dextrose (YPD) medium, harvested them at the indicated time points, stained them with SYTOX green and then performed flow cytometry. WT and Y40A H2B mutant cells had similar cellcycle kinetics ( Supplementary  Fig. 7) . We also performed a growth analysis of Y40A H2B cells in complete growth medium and found their growth to be indistinguish able from that of WT yeast cells (data not shown), which suggests that the higher histone mRNA levels observed in the Y40A H2B mutant are not caused by altered cell growth or an altered cell cycle. pTyr37 H2B suppresses NPAT and RNA polymerase II binding Histone transcriptional activation in mammalian cells has been well studied: for example, NPAT has been shown to have an essential role in the transcriptional activation of histone genes by its recruitment, along with that of RNA polymerase II, at both Hist clusters, Hist1 and Hist2 (refs. 36,37) . On the basis of its histone mRNA profile, we reasoned that H2B Tyr37 phosphorylation could potentially modulate histone transcription by its interaction with NPAT and RNA polymerase II. To test this hypothesis, we immunoprecipitated chromatin from synchronized MEFs at 6.5 h after thymidine release with NPAT or RNA polymerase II antibodies, which we followed with qPCR. Although we did not find recruitment of NPAT or RNA polymerase II when H2B Tyr37 phosphorylation was optimal, we did detect binding of both NPAT and RNA polymerase II when the phosphorylation was abrogated by treatment with the WEE1 inhibi tor (Fig. 5a-c) . The recruitment of NPAT and RNA polymerase II was minimal at the control site (Supplementary Fig. 8a,b) . To con firm that the presence of RNA polymerase II at site 2 was dependent on NPAT, we transfected MEFs with control and NPAT siRNAs and immunoprecipitated chromatin with RNA polymerase II antibodies, which we followed with qPCR. The binding of RNA polymerase II at site 2 was markedly decreased by the depletion of NPAT by siRNA (Supplementary Fig. 8c,d ). 
a r t i c l e s
To further understand the mechanism underlying the loss of NPAT binding to site 2 when H2B is phosphorylated at Tyr37, we performed a pulldown assay with biotinconjugated H2B peptides spanning amino acids 25-49 (referred to here as H2B ) and pTyr37 H2B peptides. We immobilized the H2B and pTyr37 H2B pep tides on streptavidinSepharose beads and then incubated them with wholecell extracts of HEK 293 cells. We washed the beads and ana lyzed the bound protein by immunoblotting with NPAT antibodies. Although NPAT specifically bound to the unmodified H2B peptide, this binding was abolished when the peptide was phosphorylated at Tyr37 (Fig. 5d) . We further confirmed the specificity of NPAT for unphosphorylated H2B using a filterbinding assay wherein the mem brane spotted with peptides was incubated with HEK 293 lysates and probed with NPAT antibodies (Fig. 5e) .
To assess the dynamics of NPAT binding, we performed ChIP using NPAT antibodies for the samples collected at 0 h, 2 h, 4 h, 6.5 h or 7.25 h after thymidine release, followed by qPCR for site 2 and the control site. These analyses revealed optimal recruitment of NPAT at site 2 at 2 h after release, and this recruitment continued at 4 h after release; however, at 6.5 h after thymidine release, when H2B is phosphorylated at Tyr37 (as well as after that time point), NPAT binding at site 2 was markedly diminished (Fig. 5f) . To determine whether NPAT could interact with WEE1 kinase, we performed a coimmunoprecipitation assay. NPAT bound to WEE1 but did not interact with a WEE1 deletion mutant lacking the Nterminal regula tory domain (Supplementary Fig. 9a,b) . This finding, together with the ChIP data, suggests that NPAT recruits WEE1 and that WEE1 phosphorylates H2B and excludes NPAT and RNA polymerase II from binding upstream of Hist1 cluster.
H2B Tyr37 phosphorylation recruits HIRA
Researchers from a previous study identified a negative regulatory site in S. cerevisiae, named the NEG or CCR region, in the promoters of six of the eight yeast histone genes (HTA1HTB1, HHT1HHF1 and HHT2HHF2) 38 . They identified four evolutionarily conserved trans acting factors, HIR1, HIR2, HIR3 and HPC2, that bind the negative regulatory site to repress histone transcription 8, 39 . These four pro teins form the HIR corepressor complex, also known as the histone chaperone complex 40, 41 . The concentrations of the HIR proteins are not regulated by the cell cycle [42] [43] [44] , which has led to the identification of regulation wherein histone transcription outside of the S phase is actively inhibited by the interaction of the HIR complex with two other H3 and H4 histone chaperones, Asf1 and Rtt106 (ref. 45) . Unlike yeast, humans have a single HIRA protein, histone regula tory homolog A, which is also a component of the histone chaperone complex that spreads across silenced domains to enforce transcrip tional silencing 46, 47 . We observed that H2B Tyr40 phosphorylation is enriched in the HTA1HTB1 promoter region containing the NEG site, where members of the HIR complex localize ( Supplementary  Fig. 6c,d) . Ectopic overexpression of HIRA has been reported to suppress histone transcription 48 . On the basis of these data, we hypothesized that HIRA could be involved in the transcriptional suppression mediated by pTyr37 H2B in mammalian cells. To assess whether H2B Tyr37 phosphorylation at site 2 resulted in the recruit ment of HIRA, we immunoprecipitated chromatin from synchro nized MEFs with HIRA antibodies, which we followed with qPCR. HIRA was recruited at site 2 when H2B was phosphorylated at Tyr37; however, the binding of HIRA was abrogated when we added the WEE1 inhibitor, which suppressed the phosphorylation of H2B (Fig. 5g) . To further confirm HIRA binding to site 2 when H2B is phosphorylated at Tyr37, we performed a pulldown assay with biotin conjugated H2B peptides, as described above. HIRA specifically asso ciated with the Tyr37phosphorylated H2B peptide; however, the binding of HIRA to the phosphorylated peptide was markedly lower than its binding to the unmodified H2B peptide (Fig. 5h) .
To perform a comparative assessment of WEE1 and HIRA knock down on histone transcription, we transfected MEFs with control siRNA, HIRAspecific siRNA or WEE1specific siRNA. Consistently with earlier data (Fig. 3) , we found a marked decrease in histone mRNA levels in the samples transfected with control siRNA at 6.5 h after thymidine release but not in the samples transfected with WEE1 siRNA (Supplementary Fig. 9c-f) . Notably, samples transfected with HIRA siRNA had overall higher histone mRNA levels than the sam ples transfected with control siRNA. Collectively, these data indicate that WEE1mediated H2B Tyr37 phosphorylation at 6.5 h after thymi dine release dislodges NPAT, leading to a drop in transcription in the npg a r t i c l e s samples transfected with control siRNA. HIRA binding to Tyr37 phosphorylated H2B might prevent NPAT rebinding, and, thus, when HIRA was knocked down, because Tyr37 phosphorylation was intact, NPAT would be excluded, leading to a decrease in histone mRNA levels after 6.5 h after thymidine release. However, it is possible that NPAT exclusion is not efficiently accomplished in the absence of HIRA, leading to overall increased levels of histone mRNAs.
DISCUSSION
Collectively, our data unveil a previously unknown mechanism wherein marking chromatin specifically upstream of a major histone gene cluster, Hist1, with H2B Tyr37 phosphorylation by WEE1 tyro sine kinase suppressed the transcription of mammalian histone genes by excluding NPAT and RNA polymerase II and promoting HIRA recruitment (Fig. 6) . This mechanism seems to be evolutionarily conserved, including in yeast, where phosphorylation of H2B Tyr40 (the equivalent of the mammalian H2B Tyr37 site) suppressed the transcription of the HTA1HTB1, HTA2HTB2 and HHF1HHT1 loci. Notably, there were marginally higher HTT2 mRNA levels in Y40A and swe1∆ mutant yeast cells compared to WT yeast cells (data not shown), suggesting that H2B Tyr40 phosphorylation has a modest role in the transcriptional suppression of the HHT2HHF2 locus.
The signaling mechanisms and effectors of most tyrosine kinases are well understood, but the majority of these effectors are trans membrane or cytoplasmic proteins. How tyrosine kinases regulate gene expression by directly modulating chromatin is not fully understood. So far there have been three reports of histone tyro sine phosphorylation, one in the variant histone H2AX and two in the core histone H3 (ref. 12) . The Nterminal domain of WSTF (WilliamsBeuren syndrome transcription factor) phosphorylates H2AX at Tyr142, which was shown to be crucial for the DNA damage response 49 , apoptosis and survival 50 . JAK2, a nonreceptor tyrosine kinase, has been shown to phosphorylate histone H3 at Tyr41, preventing the binding of heterochromatin protein 1α 51 . Histone H3 was also shown to be phosphorylated at Tyr99 in yeast, and H3 phosphorylation at Tyr99 is crucial for H3 turnover by ubiquitylation and degradation 52 .
In our quest to identify the kinase that could robustly phosphor ylate H2B in vivo, we tested a large number of mammalian kinases, both membrane bound and nonreceptor type, but none of them could robustly phosphorylate H2B in vivo. Our MEF data revealed that H2B Tyr37 phosphorylation is highly regulated by the cell cycle (Figs. 1a  and 3a,b) . In our studies with the yeast Tyr40 mutant, we observed that it had a significantly higher histone mRNA level than WT yeast. These two observations together gave an important clue: there is one well studied tyrosine kinase in S. cerevisiae, SWE1, that is activated in a cell cycle-dependent manner. Therefore, SWE1 (and, hence, WEE1) could be the candidate kinase for H2B tyrosine phosphorylation. Subsequent experiments confirmed the role of WEE1 and SWE1 in mammalian and yeast histone mRNA transcription, respectively.
When we assessed the HTA2HTB2 gene pair in the swe1∆ mutant, it also showed a robustly higher mRNA level than WT yeast (Fig. 4) . HIRmediated repression of transcription relies on a specific DNA sequence: the negative regulatory element (NEG), which is found in the promoters of the three HIRregulated gene pairs but is absent in HTA2 HTB2 (refs. 8,38 ). There could be two possible scenarios for transcrip tional increase of the HTA2HTB2 gene pair: it has been shown that that constitutive expression of Hir1 and Hir2 can bypass the require ment for the NEG site, leading to suppression of the transcription of HTA2HTB2 (ref. 44) . Based on our data showing HIRA binding to pTyr37 H2B in mammalian cells (Fig. 5g,h) , it is not too farfetched to think that H2B Tyr40 phosphorylation could recruit HIR1 and HIR2 protein efficiently at upstream activation elements in the HTA2HTB2 promoter, resulting in transcriptional suppression. Another potential scenario could be the involvement of Spt10 and Spt21 proteins, dele tion of which reduces the levels of all core histone gene transcripts to some degree 53, 54 . Spt10 in complex with Spt21 binds to the HTA2 HTB2 promoter during the S phase. At the end of the S phase, the Spt10-Spt21 complex is displaced from the HTA2HTB2 promoter to shut down mRNA synthesis. The mechanism of the displacement of the Spt10-Spt21 complex from the HTA2HTB2 promoter is not fully understood. We anticipate that H2B Tyr40 phosphorylation in the HTA2HTB2 promoter has a role in this displacement, similar to the way the NPAT and RNA polymerase II complex is displaced because of H2B Tyr37 phosphorylation at site 2 in mammalian cells (Fig. 6) .
Overall, whether in mammals or in yeast, H2B Tyr37 phosphoryla tion seems to be vital to cellular homeostasis; in combination with histone mRNA turnover, repression of histone transcription could efficiently and rapidly lower the amount of transcript, eliminating overload of the core histones after DNA synthesis. To our knowledge, this report provides the first demonstration of tyrosine phosphoryla tion of H2B and the elucidation of its role in maintaining histone mRNA levels in eukaryotic cells. Further, this work also uncovers a previously unknown function of WEE1, a cellcycle regulator that has a dual role as an epigenetic modifier that also maintains the amount of histone transcripts. Figure 6 A model of H2B Tyr37 phosphorylation upstream of the major histone gene cluster Hist1 suppresses histone mRNA transcription. WEE1 phosphorylates H2B at Tyr37 upstream of histone cluster 1, Hist1. NPAT is excluded from binding to the Hist1 cluster because of its inability to recognize Tyr37-phosphorylated H2B, which in turn inhibits RNA polymerase II (Pol II) recruitment. Subsequently, HIRA is recruited to Tyr37-phosphorylated H2B, preventing NPAT rebinding and effectively resulting in the suppression of histone mRNA synthesis.
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ONLINE METHODS
Mass spectrometric identification of H2B tyrosine phosphorylation sites. The purified histones were subjected to SDSPAGE electrophoresis and stained with Coomassie Brilliant BlueR250 (BioRad), and a band of ~14 kDa was excised. Trypsin ingel digestion was performed, and the extracted peptides were analyzed by liquid chromatography tandem mass spectrometry (LCMS/MS). A nanoflow liquid chromatograph coupled to an electrospray ion trap mass spectrometer (LTQOrbitrap) was used for MS/MS peptidesequencing experiments. Five tan dem mass spectra were collected in a datadependent manner after each survey scan. The MS scans were performed in Orbitrap to obtain accurate peptide mass measurement, and the MS/MS scans were performed a in linear ion trap using a 60s exclusion for previously sampled peptide peaks. Sequest 55 and Mascot 56 searches were performed against the SwissProt human database.
Generation and affinity purification of the pTyr37 H2B antibody. Two H2B peptides coupled to immunogenic carrier proteins were synthesized as shown below, and pTyr37 H2B antibodies were custom synthesized by 21 st Century Biochemicals, MA. Ahx is aminohexanoic acid, which is sixcarbon spacer used to distance the carrier protein KLH from immunogen.
Phosphopeptide: acetylKRSRKES[pY]SVYVYKVLAhxCamide
Nonphosphopeptide: acetylKRSRKESYSVYVYKVLAhxCamide Two rabbits were immunized twice with the phosphopeptide, and the sera from these rabbits was affinity purified. Two antigenaffinity columns were used to purify the phosphospecific antibodies. The first column was the nonphosphopeptide affinity column. Antibodies recognizing the unphos phorylated residues of the peptide bound to the column. The flowthrough fraction was collected and then applied to the second column, the phos phopeptide column. Antibodies recognizing the phospho residue bound to the column and were eluted as phosphospecific antibodies. The monoclonal pTyr37 H2B antibody expressing hybridoma was custom generated by ProMab Biotechnologies, CA.
Cell synchronization using a double thymidine block. MEFs or H1975 cells (obtained from American Type Culture Collection) were grown to 60-70% con fluency. Thymidine was added at a final concentration of 2 mM, and the cells were incubated for 17 h. Cells were then washed, and fresh serumcontaining medium was added. After 10 h, thymidine was added again, and the cells were incubated for 17 h; cells were then washed, replaced with fresh serumcontaining medium, and data were collected at the indicated time points.
Native ChIP sequencing and analysis. Synchronized MEFs were harvested at indicated time points after thymidine release (5 × 10 7 cells). Cells pellets were resuspended in receptor lysis buffer 57,58 and sonicated for 25 s to shear the DNA to an average length of 300-500 bp. The soluble chromatin was incubated overnight at 4 °C with pTyr37 H2B antibody and 20 µl of proteinG magnetic beads (Active motif). The complexes were washed with ChIP buffer 1 and 2 (Active Motif) and eluted with elution buffer. Immunoprecipitated DNA was subjected to proteinase K treatment for 2 h. Chromatin immuno precipitated DNAs were subjected to sequencing. The sequencing yield was very good, with almost 40 million reads in each sample, of which 27.7 and 23.6 million for samples at 6.5 h and 0 h, respectively, mapped uniquely to the mouse mm9 genome.
Sequence analysis. The 36nt sequence reads ('tags') identified by the Sequencing Service (using Illumina's Genome Analyzer 2) were mapped to the genome using the ELAND algorithm. Alignment information for each tag was stored in the output file *_export.txt. Only tags that mapped uniquely, had no more than two mismatches and that passed quality control filtering were used in the subsequent analysis.
Determination of fragment density. Because the 5′ ends of the sequence tags rep resent the end of the ChIP or immunoprecipitation fragments, the tags were extended in silico (using Active Motif software) at their 3′ ends to a length of 110-200 bp, depending on the average fragment length in the sizeselected library. This information is stored in a BAR (Binary Analysis Results) file that can be viewed in a browser such as Affymetrix' Integrated Genome Browser (IGB).
Interval analysis ('peak finding' ). An 'interval' is a discrete genomic region defined by the chromosome number and a start and end coordinate. For each BAR file, intervals are calculated and compiled into BED (Browser Extensible Data) files. A typical threshold setting is in the range of 10-20 but may be adjusted depending on the number of tags sequenced or based on the infor mation on positive and negative test sites, independent estimates for the false discovery rate and/or the intent to generate a stringent or relaxed analysis. For an interval to be called, it must contain three consecutive bins with fragment densities greater than the threshold.
Alternative and/or optional analysis steps. (i) Tag normalization: when samples had uneven tag counts, the tag numbers of all the samples were truncated to the number of tags present in the smallest sample. (ii) False peak filtering: input or IgG control samples (which represent false peaks) were used to remove corresponding intervals in ChIP samples or to mark them as probable false positives.
Active-region analysis. To compare peak metrics between two or more samples, overlapping intervals are grouped into 'active regions' , which are defined by the start coordinate of the most upstream interval and the end coordinate of the most downstream interval (equal to the union of overlapping intervals).
In vitro kinase assay. For the in vitro kinase assay, 340 ng of purified glutathione Stransferase (GST)WEE1 (Invitrogen) and 1 µg of H2A, H2B, H3 or H4 (NEB) were incubated in the presence or absence of the WEE1 inhibitor MK1775 (0.625 µM) in WEE1 kinase assay buffer containing 50 mM HEPES (pH 7.5), 15 mM MgCl 2 , 1 mM EGTA, 10% glycerol, 10 mM DTT and 0.1 mM ATP at 30 °C. After 60 min, the reaction was separated by SDSPAGE (18%), followed by immunoblottings with pTyr37 H2B, total H2B, H2A, H3, H4 and WEE1 antibodies.
